RecruitingNCT05819528
Primary Cardiac Lymphoma: Italian Multicenter Experience
Sponsor
Fondazione Italiana Linfomi - ETS
Enrollment
43 participants
Start Date
Oct 2, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
The rationale of this study is to provide an overview on PCL (Primary Cardiac Lymphoma) in Italy, trying to shed light on unknown aspects of the disease and on unanswered questions about its management that could be helpful in clinical practice.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This registry collects information from Italian hospitals about patients diagnosed with primary cardiac lymphoma (PCL) — an extremely rare type of cancer that starts in or around the heart. Because so few cases exist, this multicenter study aims to pool data to better understand how patients are diagnosed, treated, and how they do over time.
**You may be eligible if...**
- You have been diagnosed with primary cardiac lymphoma (cancer originating in the heart or its surrounding sac) confirmed by biopsy or specific fluid analysis
- You are 18 or older
- Your diagnosis was made from January 1990 onward
**You may NOT be eligible if...**
- Your lymphoma did not originate in the heart (i.e., it is a secondary spread from lymphoma elsewhere)
- Diagnosis has not been histologically confirmed
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(17)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05819528